NIH-funded research R01 grant

Using continuous glucose monitoring to improve blood sugar control in dialysis patients

Official title: Continuous Glucose Monitoring in Dialysis Patients to Overcome Dysglycemia (CONDOR) Trial

Funded at University of California Los Angeles · NIH-11047742 · Data updated 2026-11-12

This study is looking at how using continuous glucose monitoring can help people with diabetes who are on dialysis keep their blood sugar levels stable and avoid dangerous lows, making it easier for them to manage their health.

More Dialysis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startDecember 21, 2023
Project endJanuary 31, 2026
Funding year2025
Award (this year)$232,020
NIH project number5R01DK132869-03
Project IDNIH-11047742 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older who are undergoing dialysis and have diabetes.

Less likely to help

Patients who do not have diabetes or are not undergoing dialysis may not benefit from this research.

What this research studies

This research investigates the use of continuous glucose monitoring (CGM) to help manage blood sugar levels in patients undergoing dialysis due to diabetes. The study aims to address the high risk of hypoglycemia in these patients, which can lead to serious health complications. By providing real-time glucose data, the research seeks to improve glycemic control and reduce the associated risks of cardiovascular issues and psychological stress. Participants will be monitored closely to assess the effectiveness of CGM compared to traditional blood glucose monitoring methods.

Why it matters

Potential benefit: If successful, this research could significantly improve blood sugar management and overall health outcomes for dialysis patients with diabetes.

How similar studies have gone: Previous research has shown promising results with continuous glucose monitoring in other diabetic populations, suggesting potential for success in this novel application.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Rhee, Connie Meeyoung — University of California Los Angeles
  • Study coordinator: Rhee, Connie Meeyoung

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.